October 10, 2022

ARTARMON, Australia, Oct. 4, 2022 /PRNewswire/ — Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced neural activation and sensing technologies, today announced the appointment of Laureen DeBuono to its board of directors and Chair of the company’s Audit Committee.

Full press release is here.